LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | OSI-027 | 3.33 | uM | LJP6 | 3 | E08 | 72 | hr | 868 | 2131 | 3486 | 0.6112 | 0.4823 |
MDA-MB-231 | XMD11-85h | 3.33 | uM | LJP6 | 1 | P20 | 72 | hr | 868 | 2420 | 3486 | 0.6941 | 0.5927 |
MDA-MB-231 | XMD11-85h | 3.33 | uM | LJP6 | 2 | P20 | 72 | hr | 868 | 2553 | 3486 | 0.7323 | 0.6435 |
MDA-MB-231 | XMD11-85h | 3.33 | uM | LJP6 | 3 | P20 | 72 | hr | 868 | 2398 | 3486 | 0.6878 | 0.5843 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 868 | 870 | 3486 | 0.2495 | 0.0007 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 868 | 1037 | 3486 | 0.2974 | 0.0645 |
MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 868 | 1228 | 3486 | 0.3522 | 0.1375 |
MDA-MB-231 | WH-4-025 | 3.33 | uM | LJP5 | 1 | O08 | 72 | hr | 868 | 793 | 3486 | 0.2275 | -0.0287 |
MDA-MB-231 | WH-4-025 | 3.33 | uM | LJP5 | 2 | O08 | 72 | hr | 868 | 815 | 3486 | 0.2338 | -0.0203 |
MDA-MB-231 | WH-4-025 | 3.33 | uM | LJP5 | 3 | O08 | 72 | hr | 868 | 826 | 3486 | 0.2369 | -0.0161 |
MDA-MB-231 | WZ-4-145 | 3.33 | uM | LJP6 | 1 | J20 | 72 | hr | 868 | 2669 | 3486 | 0.7656 | 0.6878 |
MDA-MB-231 | WZ-4-145 | 3.33 | uM | LJP6 | 2 | J20 | 72 | hr | 868 | 2491 | 3486 | 0.7145 | 0.6198 |
MDA-MB-231 | WZ-4-145 | 3.33 | uM | LJP6 | 3 | J20 | 72 | hr | 868 | 2456 | 3486 | 0.7045 | 0.6065 |
MDA-MB-231 | XMD16-144 | 3.33 | uM | LJP5 | 1 | M08 | 72 | hr | 868 | 1172 | 3486 | 0.3362 | 0.1161 |
MDA-MB-231 | XMD16-144 | 3.33 | uM | LJP5 | 2 | M08 | 72 | hr | 868 | 1362 | 3486 | 0.3907 | 0.1886 |
MDA-MB-231 | XMD16-144 | 3.33 | uM | LJP5 | 3 | M08 | 72 | hr | 868 | 1221 | 3486 | 0.3502 | 0.1348 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 1 | P14 | 72 | hr | 868 | 2335 | 3486 | 0.6698 | 0.5603 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 2 | P14 | 72 | hr | 868 | 3258 | 3486 | 0.9345 | 0.9128 |
MDA-MB-231 | Brivanib | 3.33 | uM | LJP5 | 3 | P14 | 72 | hr | 868 | 2755 | 3486 | 0.7902 | 0.7207 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 1 | H02 | 72 | hr | 868 | 1139 | 3486 | 0.3267 | 0.1035 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 2 | H02 | 72 | hr | 868 | 1072 | 3486 | 0.3075 | 0.0779 |
MDA-MB-231 | Buparlisib | 3.33 | uM | LJP5 | 3 | H02 | 72 | hr | 868 | 1195 | 3486 | 0.3428 | 0.1249 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 1 | L20 | 72 | hr | 868 | 1404 | 3486 | 0.4027 | 0.2047 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 2 | L20 | 72 | hr | 868 | 1574 | 3486 | 0.4515 | 0.2696 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 3 | L20 | 72 | hr | 868 | 1376 | 3486 | 0.3947 | 0.1940 |